EUVIMEDEUVIMED entdecken
Crossref

Three-Dimensional Bioprinting-Enabled Organoids for Engineering the Tumor Microenvironment

Yehua Li iD, Jiale Shi iD, Qin Zhang, Hai Huang, Shen'ao Zhou

Tissue Engineering Part B: Reviews · 22.07.2026

DOI: 10.1177/19373368261469463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tissue Engineering Part B: Reviews, online erschienen am 22.07.2026. Verfasst von Yehua Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science, Northwest Normal University, Lanzhou, China. Die Arbeit nennt 162 Literaturangaben. Gefördert von: Shanghai Rising-Star Program, the Shanghai Leading Talent Program of Eastern Talent Plan, Natural Science Foundation of the Science and Technology Innovation Action Plan of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment (TME) is a complex and dynamic system composed of immune cells, stromal cells, and extracellular matrix (ECM), whose composition and spatial architecture critically influence tumor initiation, progression, invasion, metastasis, and response to immunotherapy. However, traditional research models such as two-dimensional cell coculture, patient-derived xenograft models, and conventional patient-derived organoid (PDO) systems remain limited in simulating the complexity and physiological relevance of the TME. Three-dimensional (3D) bioprinting technology, with its precise spatial control capabilities and advantages in multicellular integration, has emerged as a promising engineering tool for constructing TME-like models with controlled spatial architecture, tunable matrix properties, and programmable multicellular organization. This review examines the principles and capabilities of major 3D bioprinting technologies (extrusion-based, droplet-based, photopolymerization-based) and evaluates their applications in reconstructing key TME features such as matrix remodeling, vascularization, immune cell integration, and drug response modeling with organoids. Importantly, we distinguish between bioprinted organoid-based systems and bioprinted tumor cell models, highlighting their differences in biological fidelity and translational relevance. In addition, challenges including limited integration of PDO, constraints in multicellular coculture, and insufficient long-term functional stability continue to restrict the physiological relevance of these models. Overall, this review provides an engineering-oriented perspective on the current state of bioprinted TME models and outlines practical directions for developing more physiologically relevant platforms for cancer research, drug screening, and precision oncology.

Schlagwörter

Stichwörter der Autor:innen

3D bioprintingdrug screeningorganoidstumor microenvironment

Autor:innen und Institutionen

  • College of Life Science, Northwest Normal University, Lanzhou, China.
  • Institute of Medical Research, Northwestern Polytechnical University, Xi'an, China.
  • Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Urology, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Urology, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, China.
  • State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, CAS, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Sh…

ORCID-Profile: Yehua Li, Jiale Shi

Förderung

  • Shanghai Rising-Star Program
  • the Shanghai Leading Talent Program of Eastern Talent Plan
  • Natural Science Foundation of the Science and Technology Innovation Action Plan of Shanghai
  • National Natural Science Foundation of China
  • Science and Technology Plan Project of Lanzhou

Zitieren

APA

Li, Y., Shi, J., Zhang, Q., Huang, H., & Zhou, S. (2026). Three-Dimensional Bioprinting-Enabled Organoids for Engineering the Tumor Microenvironment. Tissue Engineering Part B: Reviews. https://doi.org/10.1177/19373368261469463

Vancouver

Li Y, Shi J, Zhang Q, Huang H, Zhou S. Three-Dimensional Bioprinting-Enabled Organoids for Engineering the Tumor Microenvironment. Tissue Engineering Part B: Reviews. 2026. doi:10.1177/19373368261469463

BibTeX
@article{Li2026,
  author = {Li, Yehua and Shi, Jiale and Zhang, Qin and Huang, Hai and Zhou, Shen'ao},
  title = {Three-Dimensional Bioprinting-Enabled Organoids for Engineering the Tumor Microenvironment},
  journal = {Tissue Engineering Part B: Reviews},
  year = {2026},
  doi = {10.1177/19373368261469463}
}
Kostenlos starten →